Search

everythinglearnresearchcommunity

for

Search:↓

Dermoscopy effectively diagnoses and evaluates female hair loss treatment.

Apoptosis may contribute to hair loss in androgenetic alopecia.

FAPD and possibly CCCA may be AGA subtypes, and treatments combining antiandrogens, hair growth agents, hair transplants, and anti-inflammatories could be effective.

Hair loss is due to thinner hairs, not less hairs; hair diameter indicates balding progression and treatment effectiveness.

AGA more common in men, Koreans have lower rates and unique patterns.

Androgenetic alopecia in women needs more research and better management strategies.

The document concludes that careful evaluation is key to diagnose and treat women with hair loss, with tests for thyroid, iron, and hormones as needed.

Hair loss in males involves inflammation, collagen buildup, and follicle damage, with severity increasing with age and baldness duration.

Fibrosing alopecia in a pattern distribution is a hair loss condition often confused with other types, requiring early treatment but usually not resulting in significant hair regrowth.

Men with common hair loss may have a higher risk of heart disease and diabetes, and should be checked for these conditions.

Fibrosing alopecia in a pattern distribution is a unique hair loss condition that may respond to antiandrogen therapy.

The document concludes that new methods improve the accuracy of diagnosing scalp alopecia and challenges the old way of classifying it.

Southern Chinese women with female pattern hair loss have less, thinner hair and smaller hair follicles.

Baldness, especially at the front, may lower the risk of testicular cancer by 31%, but its link to prostate cancer is unclear.

Avoiding allergens can improve skin and hair conditions in adults with allergic reactions.

Male hair loss is mainly due to thinner hair, not less hair.

Surgical hair replacement is a viable option for male pattern baldness when done with proper planning and realistic expectations.

Stem cells preservation in AGA could be a potential therapy, but more cases needed.

AGA is a common hair loss affecting both genders, treated with various therapies to promote regrowth and slow thinning.

AGA causes hair loss by shrinking hair follicles due to DHT binding, and can be treated with finasteride and minoxidil.

The conclusion is that accurate diagnosis of different types of hair loss requires good teamwork between skin doctors and lab experts.

Telogen effluvium is a common type of hair loss that can resolve on its own or become chronic, with treatment depending on early diagnosis.

Trichoscopy can diagnose female hair loss with high accuracy by looking for specific patterns in hair and scalp appearance.

The document concludes that accurate diagnosis of different types of hair loss requires careful examination of hair and scalp tissue, considering both clinical and microscopic features.

No cure for female pattern hair loss, but various effective treatments exist.

High levels of testosterone and 5α-DHT can lead to cell death in cells important for hair growth.

Women's hair generally gets thinner and less dense starting in their mid-thirties, with hair loss becoming more common as they age due to both genetics and environment.

AGA patients have fewer hairs and smaller follicles; T:V ratio above 4:1 may indicate AGA.

Dutasteride more effectively treats hair loss than finasteride, but may increase risk of altered libido.

Menopause-related hormonal changes affect hair but are not the only cause of hair changes in middle-aged women.